Login with your work email address to view charts. No credit card required.
| Art Unit: | 1745 — Adhesive bonding and miscellaneous chemical manufacture |
|---|---|
| Group: | 1740 — Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding |
| Classes: |
156 — Adhesive bonding and miscellaneous chemical manufacture 428 — Stock material or miscellaneous articles 228 — Metal fusion bonding 264 — Plastic and nonmetallic article shaping or treating: processes 438 — Semiconductor device manufacturing: process 219 — Electric heating 414 — Material or article handling 100 — Presses 356 — Optics: measuring and testing 297 — Chairs and seats |
| Phone: | Available with subscription |
| Email: | Available with subscription |
| Title: | Pat Examnr Cheml Engrg |
| Service: | 36 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 91% over 335 cases |
|---|---|
| Difficulty: | Very Easy |
| Difficulty Percentile: | 15th
|
With Examiner Sells, you have a 91% chance of getting an issued patent by 3 years after the first office action. Examiner Sells is a very easy examiner and in the 15th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Sells, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Sells's grant rate is higher than that of Art Unit 1745 and higher than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Sells | 0.7 |
| Art Unit 1745 | 1.6 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.